INFORMATION RIGHTS AGREEMENT DATED NOVEMBER 11, 2015Information Rights Agreement • November 12th, 2015 • Altria Group, Inc. • Cigarettes • New York
Anchiano Therapeutics Ltd.Information Rights Agreement • January 13th, 2021 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations
This letter confirms our agreement and undertaking that subject to and following the initial public offering of American Depositary Receipts representing ordinary shares of Anchiano Therapeutics Ltd. (the “Company”) on the Nasdaq Global Market, Clal Biotechnology Industries Ltd. (the “Shareholder”) shall be entitled to the information rights set forth in this letter agreement (this “Agreement”), subject to the terms set forth herein.
RECITALSInformation Rights Agreement • May 27th, 1999 • Cobalt Group Inc • Washington
INFORMATION RIGHTS AGREEMENTInformation Rights Agreement • October 3rd, 2017 • Delaware
This Information Rights Agreement, dated as of October , 2017 (this “Agreement”), is entered into by and between VICI Properties Inc., a Maryland corporation (together with its direct and indirect subsidiaries, “REIT”), and Caesars Enterprise Services, LLC a Delaware limited liability company (“CES”). REIT and CES are sometimes referred to collectively in this Agreement as the “Parties” and individually as a “Party”.
INFORMATION RIGHTS LETTERInformation Rights Agreement • April 19th, 2017 • GDS Holdings LTD • Services-computer programming, data processing, etc. • New York
Gamida Cell Ltd. Givaat Shaul, Jerusalem 91340 IsraelInformation Rights Agreement • October 17th, 2018 • Gamida Cell Ltd. • Biological products, (no disgnostic substances)
This letter confirms our agreement and undertaking that subject to and following the initial public offering of the ordinary shares of Gamida Cell Ltd. (the “Company”) on the Nasdaq Global Market, [Clal Biotechnology Industries Ltd./ Elbit Cord Blood Limited Partnership] (the “Shareholder”) shall be entitled to the information rights set forth in this letter agreement (this “Agreement”), subject to the terms set forth herein.
MediWound Ltd. Yavne IsraelInformation Rights Agreement • March 3rd, 2014 • MediWound Ltd. • Medicinal chemicals & botanical products
This letter confirms our agreement and undertaking that subject to and following the initial public offering of the ordinary shares of MediWound Ltd. (the “Company”) on the Nasdaq Global Market, provided that such offering is consummated not later than August 31, 2014, Clal Biotechnology Industries Ltd. (the “Shareholder”) shall be entitled to the information rights set forth in this letter agreement (this “Agreement”), subject to the terms set forth herein.
Clal Biotechnology Industries Ltd. Azrieli Center, Triangular Tower, 45th Floor Tel Aviv, IsraelInformation Rights Agreement • June 2nd, 2023 • Elicio Therapeutics, Inc. • Pharmaceutical preparations • Delaware
§ 57D-3-04. Information rights.Information Rights Agreement • February 10th, 2022
ANHEUSER-BUSCH INBEV SA/NV - and - ALTRIA GROUP, INC. INFORMATION RIGHTS AGREEMENT DATED NOVEMBER 11, 2015Information Rights Agreement • March 22nd, 2017 • Anheuser-Busch InBev SA/NV • Malt beverages • New York
Vedantra Pharmaceuticals, Inc.] One Kendall SquareInformation Rights Agreement • June 28th, 2021 • Elicio Therapeutics, Inc. • Pharmaceutical preparations • Delaware
INFORMATION RIGHTS AGREEMENTInformation Rights Agreement • October 10th, 2018 • Charah Solutions, Inc. • Hazardous waste management • Delaware
THIS INFORMATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of October 9, 2018 by and between Charah Solutions, Inc. (the “Company”) and Bernhard Capital Partners Management, LP (“BCP”).
